# Silenor

NDC: 42847-103
Generic name: doxepin hydrochloride
Labeler / Manufacturer: Currax Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20100801

FDA application: NDA022036

## Active ingredients

- DOXEPIN HYDROCHLORIDE: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42847-103"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42847-103
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bec1223-5239-4eb6-a9e8-62444106d2c0